Kursprognose für Traws Pharma Inc (TRAW)TRAWTraws Pharma Inc

Alphio's TRAW stock price prediction model matches the current Traws Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (+1.86%). The 1-week path is $0.24 (+3.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Traws Pharma Inc is not a good buy right now due to significant financial instability and negative market sentiment. The current price is $0.2271, which is down 82.92% year-to-date, indicating a severe decline in value. Additionally, the RSI is at 11.257, suggesting the stock is heavily oversold, but this could also indicate a lack of buying interest. The company has a forward P/E of 0, reflecting uncertainty about future earnings, and a gross margin of 0% in recent quarters, showing no profitability. The main risk is the delayed study for its lead flu drug, which has already caused a 28% drop in after-hours trading, highlighting the volatility and uncertainty surrounding the stock.

Traws Pharma Inc (TRAW) last closed at $0.2271, gaining +3.18%. These facts feed the 1-day and 1-week TRAW price prediction above.